Date Title Description PDF
23 Feb 2022 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
23 Feb 2022 On business and financial situation The Company releases the press release related to the full year 2021 financial results Download
23 Feb 2022 On business and financial situation The Company releases the full year 2021 financial results presentation Download
22 Feb 2022 On buy-back programmes ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.     Download
16 Feb 2022 On business and financial situation Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years       Download

Pages

Date Title Description PDF
04 Jul 2022 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2022 Download
30 Jun 2022 Other relevant information The Company informs about the dividends payment Download
16 Jun 2022 Other relevant information The Company has agreed to execute the capital reduction approved by the 2022 Ordinary General Meeting to amortize the shares acquired in the framework of the own shares repurchase programs   Download
14 Jun 2022 Announcement of general shareholders’ meeting ROVI releases the information related to its General Shareholders Meeting Download
11 May 2022 On business and financial situation The Company releases the press release related to the first quarter 2022 financial result Download

Pages

Date Title Description PDF
18 Nov 2015 Convocatorias y acuerdos de Juntas y Asambleas generales Download
22 Oct 2015 información sobre resultados Download
22 Oct 2015 información sobre resultados (2) Download
21 Oct 2015 Otros sobre Gobierno Corporativo Download
16 Oct 2015 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download

Pages